Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 50090-6074

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 50090-6074). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Divalproex Fig1)

A line graph comparing the percent reduction in CPS rate between Divalproex Sodium Delayed-Release Tablets and placebo across the percentage of patients. The vertical axis represents improvement or worsening in CPS rate, while the horizontal axis shows the percent of patients. Two lines depict the response distributions for the drug and placebo groups.*

FDA Label Image

Figure 2 (Divalproex Fig2)

A cumulative response curve graph comparing percentage reduction in CPS rate for high dose versus low dose Divalproex sodium delayed-release tablets. The x-axis shows percentage of patients, and the y-axis shows percent reduction in CPS rate from -100% to 100%, with indicators for worsening and improvement in CPS rate.*

FDA Label Image

Fig-3 (Divalproex Fig3)

A bar graph comparing two groups: Placebo and Divalproex Sodium Extended-Release Tablets. The graph shows numerical values on the vertical axis, with the Divalproex Sodium bar significantly higher than the Placebo bar, indicating a measured difference. A statistical significance marker (p=0.006) is noted above the Divalproex bar.*

FDA Label Image

Chemical Structure (Divalproex Str)

Chemical structure of divalproex sodium, showing its molecular components including carbons, hydrogens, oxygen, and sodium ions arranged in the polymeric formula.*

FDA Label Image

Label Image (Lbl500906074)

Divalproex sodium 500 mg extended-release film-coated tablets, packaged in a bottle containing 30 tablets. The label indicates oral administration, once-daily dosing, and storage instructions to keep the product between 68 to 77 degrees Fahrenheit, protected from light. The product is labeled by A-S Medication Solutions with NDC 50090-6074.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.